• Results
  • Governance, strategy and business: How do companies prioritise access to medicin...
Governance, strategy and business

How do companies prioritise access to medicine?

Greater access to medicine for low- and middle-income countries starts with strong leadership and an actionable strategy. The Index looks at whether companies view access to medicine as a strategic issue and whether they manage it as such.

Explore further

How we measure

How we measure

The Index evaluates pharmaceutical companies in areas where they have the biggest potential and responsibility to make change, such as R&D and pricing. Find out more about the analytical framework and areas of evaluation.

Get in touch

Back to top |